106 related articles for article (PubMed ID: 15608670)
1. Cellular retinol-binding protein-I inhibits PI3K/Akt signaling through a retinoic acid receptor-dependent mechanism that regulates p85-p110 heterodimerization.
Farias EF; Marzan C; Mira-y-Lopez R
Oncogene; 2005 Feb; 24(9):1598-606. PubMed ID: 15608670
[TBL] [Abstract][Full Text] [Related]
2. CRBP suppresses breast cancer cell survival and anchorage-independent growth.
Kuppumbatti YS; Rexer B; Nakajo S; Nakaya K; Mira-y-Lopez R
Oncogene; 2001 Nov; 20(50):7413-9. PubMed ID: 11704871
[TBL] [Abstract][Full Text] [Related]
3. Cellular retinol-binding protein I, a regulator of breast epithelial retinoic acid receptor activity, cell differentiation, and tumorigenicity.
Farias EF; Ong DE; Ghyselinck NB; Nakajo S; Kuppumbatti YS; Mira y Lopez R
J Natl Cancer Inst; 2005 Jan; 97(1):21-9. PubMed ID: 15632377
[TBL] [Abstract][Full Text] [Related]
4. A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells.
Sekulić A; Hudson CC; Homme JL; Yin P; Otterness DM; Karnitz LM; Abraham RT
Cancer Res; 2000 Jul; 60(13):3504-13. PubMed ID: 10910062
[TBL] [Abstract][Full Text] [Related]
5. Cellular retinol-binding protein expression and breast cancer.
Kuppumbatti YS; Bleiweiss IJ; Mandeli JP; Waxman S; Mira-Y-Lopez R
J Natl Cancer Inst; 2000 Mar; 92(6):475-80. PubMed ID: 10716965
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic CRBP downregulation appears to be an evolutionarily conserved (human and mouse) and oncogene-specific phenomenon in breast cancer.
Arapshian A; Bertran S; Kuppumbatti YS; Nakajo S; Mira-y-Lopez R
Mol Cancer; 2004 Apr; 3():13. PubMed ID: 15113415
[TBL] [Abstract][Full Text] [Related]
7. Cellular retinol binding protein 1 transfection reduces proliferation and AKT-related gene expression in H460 non-small lung cancer cells.
Ferlosio A; Doldo E; Agostinelli S; Costanza G; Centofanti F; Sidoni A; Orlandi A
Mol Biol Rep; 2020 Sep; 47(9):6879-6886. PubMed ID: 32909215
[TBL] [Abstract][Full Text] [Related]
8. Dexamethasone inhibits insulin-induced chondrogenesis of ATDC5 cells by preventing PI3K-Akt signaling and DNA binding of Runx2.
Fujita T; Fukuyama R; Enomoto H; Komori T
J Cell Biochem; 2004 Oct; 93(2):374-83. PubMed ID: 15368363
[TBL] [Abstract][Full Text] [Related]
9. Apoptosis signaling by the novel compound 3-Cl-AHPC involves increased EGFR proteolysis and accompanying decreased phosphatidylinositol 3-kinase and AKT kinase activities.
Farhana L; Dawson MI; Huang Y; Zhang Y; Rishi AK; Reddy KB; Freeman RS; Fontana JA
Oncogene; 2004 Mar; 23(10):1874-84. PubMed ID: 14981538
[TBL] [Abstract][Full Text] [Related]
10. Resveratrol modulates the phosphoinositide 3-kinase pathway through an estrogen receptor alpha-dependent mechanism: relevance in cell proliferation.
Pozo-Guisado E; Lorenzo-Benayas MJ; Fernández-Salguero PM
Int J Cancer; 2004 Mar; 109(2):167-73. PubMed ID: 14750165
[TBL] [Abstract][Full Text] [Related]
11. Analysis of human cellular retinol-binding protein II promoter during enterocyte differentiation.
Zhang L; E X; Luker KE; Shao JS; Levin MS; Suh E; Li E
Am J Physiol Gastrointest Liver Physiol; 2002 Jun; 282(6):G1079-87. PubMed ID: 12016134
[TBL] [Abstract][Full Text] [Related]
12. Ganglioside loss promotes survival primarily by activating integrin-linked kinase/Akt without phosphoinositide 3-OH kinase signaling.
Sun P; Wang XQ; Lopatka K; Bangash S; Paller AS
J Invest Dermatol; 2002 Jul; 119(1):107-17. PubMed ID: 12164932
[TBL] [Abstract][Full Text] [Related]
13. Phosphatidylinositol-3-OH Kinase (PI3K)/AKT2, activated in breast cancer, regulates and is induced by estrogen receptor alpha (ERalpha) via interaction between ERalpha and PI3K.
Sun M; Paciga JE; Feldman RI; Yuan Z; Coppola D; Lu YY; Shelley SA; Nicosia SV; Cheng JQ
Cancer Res; 2001 Aug; 61(16):5985-91. PubMed ID: 11507039
[TBL] [Abstract][Full Text] [Related]
14. Direct positive regulation of PTEN by the p85 subunit of phosphatidylinositol 3-kinase.
Chagpar RB; Links PH; Pastor MC; Furber LA; Hawrysh AD; Chamberlain MD; Anderson DH
Proc Natl Acad Sci U S A; 2010 Mar; 107(12):5471-6. PubMed ID: 20212113
[TBL] [Abstract][Full Text] [Related]
15. Glucocorticoid Receptor Counteracts Tumorigenic Activity of Akt in Skin through Interference with the Phosphatidylinositol 3-Kinase Signaling Pathway.
Leis H; Page A; Ramírez A; Bravo A; Segrelles C; Paramio J; Barettino D; Jorcano JL; Pérez P
Mol Endocrinol; 2004 Feb; 18(2):303-11. PubMed ID: 14615607
[TBL] [Abstract][Full Text] [Related]
16. PI3K/Akt-dependent regulation of the transcription factor myocyte enhancer factor-2 in insulin-like growth factor-1- and membrane depolarization-mediated survival of cerebellar granule neurons.
Wiedmann M; Wang X; Tang X; Han M; Li M; Mao Z
J Neurosci Res; 2005 Jul; 81(2):226-34. PubMed ID: 15931671
[TBL] [Abstract][Full Text] [Related]
17. Immunolocalization of enzymes, binding proteins, and receptors sufficient for retinoic acid synthesis and signaling during the hair cycle.
Everts HB; Sundberg JP; King LE; Ong DE
J Invest Dermatol; 2007 Jul; 127(7):1593-604. PubMed ID: 17363914
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of the phosphatidylinositol 3-kinase/Akt pathway is involved in retinoic acid-induced phosphorylation, degradation, and transcriptional activity of retinoic acid receptor gamma 2.
Gianni M; Kopf E; Bastien J; Oulad-Abdelghani M; Garattini E; Chambon P; Rochette-Egly C
J Biol Chem; 2002 Jul; 277(28):24859-62. PubMed ID: 12032135
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of mTOR activity restores tamoxifen response in breast cancer cells with aberrant Akt Activity.
deGraffenried LA; Friedrichs WE; Russell DH; Donzis EJ; Middleton AK; Silva JM; Roth RA; Hidalgo M
Clin Cancer Res; 2004 Dec; 10(23):8059-67. PubMed ID: 15585641
[TBL] [Abstract][Full Text] [Related]
20. PS1 activates PI3K thus inhibiting GSK-3 activity and tau overphosphorylation: effects of FAD mutations.
Baki L; Shioi J; Wen P; Shao Z; Schwarzman A; Gama-Sosa M; Neve R; Robakis NK
EMBO J; 2004 Jul; 23(13):2586-96. PubMed ID: 15192701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
